Dr. Garrido Laguna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1950 Circle of Hope Dr
# Clinic
Salt Lake City, UT 84112Phone+1 801-585-0255- Is this information wrong?
Education & Training
- David Eccles School of BussinesMBA, 2021 - 2023
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2011
- Universidad de Navarra Faculty of MedicineClass of 2001
Certifications & Licensure
- UT State Medical License 2011 - 2026
- TX State Medical License 2009 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- European Union (RCPI)Medical Oncology
Clinical Trials
- A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer Start of enrollment: 2014 Jan 01
- Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer Start of enrollment: 2014 Aug 01
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Start of enrollment: 2015 Nov 19
- Join now to see all
Publications & Presentations
PubMed
- Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic...Teresa Macarulla, Patrick M Peterson, Matteo Ceccarelli, Uwe Pelzer, Faithlore P Gardner, Zev A Wainberg, Christos Fountzilas, Nathan Bahary, Mark S Womack, Ignacio Ga...> ;Cancers. 2024 Mar 28
- Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.Wattenberg, M., Colby, S., Garrido-Laguna, I., Xue, Y., Chang, R., Delman, D., Lee, J., Affolter, K., Mulvihill, S., Beg, M., Wang-Gillam, A., Wade, J., Guthrie, K., C...> ;Gastroenterology. 2024 Jan 18
- Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarci...Loriot, Y., Burgoyne, A., Santoro, A., Aix, S., Sudhagoni, R., Guo, X., Andrianova, S., Paulson, S., Li, D., Cleary, J., Lin, D., Garrido-Laguna, I.> ;Eclinicalmedicine. 2024 Jan 1
- Join now to see all
Grant Support
- THE OHIO STATE UNIVERSITY AS A LEAD ACADEMIC ORGANIZATION (LAO) FOR THE EXPERIMENTAL THERAPEUTICS CLINICAL TRIALS NETWORKNCI2020–2025
- Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic CancerNCIPresent
Committees
- Member, GI committee SWOG 2014 - Present
Professional Memberships
- European Society of Medical OncologyMember
- Spanish Society of Medical OncologyMember
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- University of Utah HealthSalt Lake City, Utah
- Huntsman Cancer HospitalSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: